ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 631371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 631371; 2) Community: the network communities that were significantly associated with the response to NSC 631371; 3) Molecule: the relationships between components within communities and NSC 631371; 4) MDR: the compounds that were significantly associated with the NSC 631371.

NSC Compound Enrichment Correlation
NSC 330500 Macbecin II 0.0139796580235794 0.46096245
NSC 351078 Hydrazinecarbothioamide, N,N-dimethyl-2-[1-(2-pyridinyl)- ethylidene]-, N-oxide 0.0139796580235794 0.36317634
NSC 46213 Null 0.0139796580235794 -0.44851126
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.0139796580235794 0.38059822
NSC 12455 Acid Alizarin Red B 0.0147237897640499 0.24065332
NSC 125066 Bleomycin sulfate 0.0147237897640499 -0.13165198
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0147237897640499 0.32762325
NSC 290193 CYCLOSPORIN A 0.0147237897640499 0.43001708
NSC 291330 Null 0.0147237897640499 0.11203165
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.0147237897640499 0.23687385
Total:127  Current:57    [First] [Prev] [Next] [Last]